Nasal vaccine for Alzheimer’s disease to begin human trials at Boston hospital

After 20 years of studies, researchers will begin the first human trial for a nasal vaccine aimed at preventing and slowing Alzheimer’s disease. Sixteen participants at Boston’s Brigham and Women’s Hospital will receive two doses of the vaccine one week apart. CBS Boston’s Zinnia Maldonado has more.

Share this:

What do you think?

Written by Headlines

Mainstream media is often "Fake News." Nevertheless, one needs to see what others are seeing and then read with discernment.

Leave a Reply

Your email address will not be published. Required fields are marked *

Deadly storm cuts Vancouver off from rest of Canada

First human trial for an Alzheimer’s nasal vaccine to begin